Modern concepts of diagnosis and therapy of iron deficiency anaemia during pregnancy;Aktuelle aspekte der diagnostik und therapie der eisenmangelanämie in der schwangerschaft

Praxis

Volumn 90, Issue 31-32, 2001, Pages 1283-1291

  Breymann, Ch ^a   Beris, Ph ^b   Furrer, J ^b   Herrmann, R ^b   Hess, O ^b   Huch, R ^b   Humbert, J ^b   Leyvraz, S ^b   Litschgi, M ^b   Nydegger, U ^b   Ruedin, P ^b   Tobler, A ^b   Walpoth, B ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NONE

Author keywords

Anaemia; Diagnostic; Iron; Pregnancy; Therapy

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ANAMNESIS; BLOOD TRANSFUSION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; IRON DEFICIENCY ANEMIA; MEDICAL EXAMINATION; PREGNANCY; REVIEW; TREATMENT PLANNING;

ANEMIA, IRON-DEFICIENCY; BLOOD TRANSFUSION; DIAGNOSIS, DIFFERENTIAL; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINOMETRY; HUMANS; INFANT, NEWBORN; IRON; PLASMA VOLUME; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; REFERENCE VALUES;

EID: 0035797552     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Broek N. Anaemia in pregnancy in developing countries. Br J Obstet Gynaecol 1998;105:385-90.
2. Türmen T. Specific problems in industrialised and developing countries: Safe motherhood, a global problem. In: Huch R, Breymann C, Huch A, editors. Prevention and management of anaemia in pregnancy and postpartum haemorrhage. Zurich, 1998:3-13.
3. Allen L. Pregnancy and iron deficiency: unresolved issues. Nutrition reviews 1997;55:91-101.
4. Bridges K. Iron imbalance during pregnancy. In: Bern M, Frigoletto F, editors. Hematologic disorders in maternal-fetal medicine. New York: Wiley-Liss, 1990:113-28.
5. Letsky A. Erythropoiesis in pregnancy. J Perinat Med 1995;23:39-45.
6. Guidozzi F, Patel R, Mc-Phail A. A prospective study of iron status in white and black pregnant women in an urban hospital. SAMJ 1995;85(3):171-173.
7. Hallberg L. Prevention of iron deficiency. Bailliere's Clinical Hematology 1994;7(4):805-814.
8. Seefried BV. Vergleichende Untersuchung von hämatologischen Parametern und des Eisenstoffwechsels von Müttern und Neugeborenen unter Anwendung der Retikulozytenflowzytometrie. [Dissertation]. Dissertation: Klinik f. Geburtshilfe, Universität Zürich, 1995.
9. Lanzkowsky P. Investigation into the aetiology and treatment of pica. Arch Dis Child 1959;34:140.
10. Cook J, Skikne B, Baynes R. Iron deficiency: The global perspective. In: Hershko C, editor. Progress in iron research. New York: Plenum Press, 1994:219-28.
11. Gardner G, Egerton V, Barnard R, Bernauer E. Cardiorespiratory, hematological and physical performance responses of anemia subjects to iron treatment. Am J Clin Nutr 1975;28:982.
12. Viteri F, Torun B. Anemia and physical work capacity. Clin Haematol 1974;3:609.
13. Kandoi A, Bhatia B, Pandey S. Cellular immunity status in anaemia in pregnancy. Indian J Med Res 1982;94:11-14.
14. Dallmann P. Iron deficiency and the immune response. Am J Clin Nutr 1987;46:329-34.
15. Kaltreider D, Johson J. Patients at high risk for low birth weight deliveries. Am J Obstet Gynecol 1976;124:251.
16. Garn S, Ridella A, Petzold S, Falkner F. Maternal haematologic values and pregnancy outcome. Semin Perinatol 1981;5:155-162.
17. Kaltreider F, Kohl S. Epidemiology of preterm delivery. Clin Obstet Gynecol 1980;23:17.
18. Scholl T, Hediger M, Fischer R, Shearer J. Aemia vs iron deficiency: increased risk of preterm delivery in a prospective study. Am J Clin nutrition 1992;55:985-8.
19. Siega-Riz A, Adair L, Hobel C. Maternal hematological changes during pregnancy and the effect of iron status on preterm delivery in a west Los Angeles population. American Journal of Perinatology 1989;15(9):515-522.
20. Cook J, Finch C, Smith N. Evaluation of the iron status of a population. Blood 1976;48:449-455.
21. Gibson R. Assessement of iron staus. In: Gibson R, editor. Principles of Nutritional Assessement. New York: Oxford University Press, 1990:349-376.
22. Perewusnyk G, Guntermann H, Breymann C, Huch R, Huch A. Bedeutung von Neopterin, Ferritin und sTfR bei der peripartalen Beurteilung des Eisenstatus. Gynäkol Geburtshilfliche Rundsch 1999;39:156.
23. Breymann C, Perewusnyk G, Guntermann H, Hänseler E, Huch R. Unrecognised iron deficiency in criticall illness. Lancet 1999;353:841-42.
24. MacDougall I, Cavill I, Hulme B, Bain B, Gregor EM, Kay PM. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992;304:225-26.
25. Schaefer R, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. J Perinat Med 1995;23:83-88.
26. Krafft A, Breymann C, Schneider J, Perewusnyk G, Huch R, Huch A. Neopterin und sTfR bei vermeintlicher «schwerer Eisenmangelanämie» in der Schwangerschaft. Gynäkol Geburtshilfliche Rundsch 1999;39:145.
27. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 1997;89(3):1052-1057.
28. Mahomed K. Routine iron supplementation in pregnancy. The Cochrane Pregnancy and Childbirth Database, 1995.
29. Hemminki E, Meriläinen J. Long-term follow-up of mothers and their infants in a randomized trial on iron prophylaxis during pregnancy. Am J Obstet Gynecol 1995;173:205-209.
30. Hollan S, Johansen K. Adequate iron stores and the «Nil Nocere» Principle. Haematologia 1993;25(2):69-84.
31. Milman N, Agger A, Nielsen O. Iron status markers and serum erythropoietin in 120 mothers and newborn infants; effect of iron supplementation in normal pregnancy. Acta Obstet Gynecol Scand 1994;73:200-204.
32. Hoigné R, Breymann C, Künzi U, Brunner F. Parenteral iron therapy: problems and possible solutions. Schweiz Med Wochenschr 1998;128:528-35.
33. Danielson B. Intravenous iron therapy-efficacy and safety of iron sucrose. In: Huch A, Huch R, Breymann C, editors. Prevention and management of anaemia in pregnancy and postpartum haemorrhage. Zurich, 1998:93-106.
34. Rohling R, Zimmermann A, Breymann C. Effectiveness of parenteral iron sucrose vs oral iron in combination with rhEPO for preoperative hematocrit increase. J Hemother and Stem Cell Res 2000; 497-500.
35. MacDougall I, Hutton R, Cavill I, Coles G, Williams J. Poor response to treatment of renal anemia with erythropoietin corrected by iron given intravenously. Br Med J 1989;299:157-58.
36. Goodnough L, Price T, Rudnick S. Iron-restricted erythropoiesis as a limitation to autologous blood donation in the erythropoietin-stimulated bone marrow. J Lab Clin Med 1991;118(3):289-296.
37. Breymann C, Richter R, Hüttner C, Huch R, Huch A. Effectiveness of rhEPO and iron sucrose Vs iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest 2000;30:154-161.
38. Breymann C, Fibach E, Visca E, Hüttner C, Huch A, Huch R. Induction of fetal Hemoglobin Synthesis with rhEPO in anemic patients with htereozygous beta-thalassemia during pregnancy. J Matern Fetal Med 1999;8:1-7.
39. Breymann C, Zimmermann R, Huch R, Huch A. Use of rhEPO in combination with parenteral iron for the treatment of postpartum anemia. European J Clin Invest 1996;23:123-26.
40. Breymann C, Major A, Richter C, Huch R, Huch A. Recombinant human erythropoietin and parenteral iron in the treatment of pregnancy anemia: a pilot study. J Perinat Med 1995;23:89-98.
41. Rosenlöf K, Kivivuori S, Riska C, Teppo A, Slimes M. Iron availability is transiently improved by intravenous iron medication in patients on chronic hemodialysis. Clin Nephrology 1995;43(4):249-255.
42. Breymann C. Modern therapy concepts for severe anaemia in pregnancy and post partum. In: Huch A, Huch R, Breymann C, editors. Prevention and management of anaemia in pregnancy and postpartum haemorrhage. Zurich, 1998:107-122.
43. Biesma D, Wiel A, Beguin Y, Kraaijenhagen R, Marx J. Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. Eur J Clin Invest 1994;24:426-432.
44. Braga J, Marques K, Branco A, Jorge C. Maternal and perinatal implications of the use of human recombinant erythropoietin. Acta Obstet Gynecol Scand 1996;75:449-453.
45. Vora M, Gruslin A. Erythropoietin in Obstetrics. Obstetrical & Gynecological Survey 1998;53(8):500-508.
46. Breymann C, Visca E., Huch R., Huch A. Efficacy and safety of recombinant human erythropoietin & parenteral iron sucrose Vs iron sucrose alone for iron deficiency anemia in pregnancy. Am J Obstet Gynecol 2001; 184: 662-667.